DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Galidesivir
Galidesivir
Remdesivir Targets a Structurally Analogous Region of the Ebola Virus and SARS-Cov-2 Polymerases
Potential Drug Candidates Underway Several Registered Clinical Trials for Battling COVID-19
Remdesivir Remdesivir (Development Code GS-5734) Is a Novel Antiviral Remdesivir Drug in the Class of Nucleotide Analogs
Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection
Potential Therapeutic Agents for COVID-19 Based on the Analysis of Protease and RNA Polymerase Docking
Infectious Disease: SARS-Cov-2 (COVID-19) Treatments
Ribavirin Shows Antiviral Activity Against SARS-Cov-2 and Downregulates the Activity of TMPRSS2 and the Expression of ACE2 in Vitro
Overview of Planned Or Ongoing Studies of Drugs for the Treatment of COVID-19
Comprehensive Analysis of Drugs to Treat SARS‑Cov‑2 Infection: Mechanistic Insights Into Current COVID‑19 Therapies (Review)
6/11/2020 – Literature Summary on Investigational and Off Label Therapies for COVID-19 1 VHA PBM Draft Literature Summary On
Therapeutic Development and Drugs for the Treatment of COVID-19
Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: from Animal Studies to Clinical Trials
Antiviral Drugs Proposed for COVID-19: Action Mechanism and Pharmacological Data
As a Treatment Type for COVID-19
Drugs Intervention Study in COVID-19 Management
COVID-19 Issues Issue 3
Researchers Race to Develop Antiviral Weapons to Ght the Pandemic
New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections Erik De Clercq*[A]
Top View
New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-Cov-2 Infection
COVID-19 and Dentistry in 72 Questions: an Overview of the Literature
Medical Product Quality Report – COVID-19 Issues
Antiviral Drugs Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection Triggering the Coronavirus Disease‑19 Pandemic Rashed Noor*
A Contemporary Look at COVID-19 Medications: Available and Potentially Effective Drugs
Bioactive Compound Library Plus (96-Well)
Therapeutic Options for the 2019 Novel Coronavirus (2019-Ncov)
COVID-19 Therapeutic Research and Development Landscape
Potential Drug Candidates Underway Several Registered Clinical Trials
Exploring the Veracity and Multi-Bioactive Potentials of Curcumin As an Arsenal for the Novel Coronavirus Disease
Journal Pre-Proof
Evaluation of 19 Antiviral Drugs Against SARS-Cov-2 Infection
Pathogenesis of Rna Virus and Recently
Ebola Hemorrhagic Fever: Recent Update on Disease Status, Current Therapies and Advances in Treatment
Role of Drug Repurposing in Current Treatment Strategies Against Covid-19; Systemic Review
Remdesivir from Wikipedia, the Free Encyclopedia
COVID-19: Finding the Right Fit Identifying Potential Treatments Using a Data-Driven Approach
Molecular Mechanisms of Galidesivir As a Potential Antiviral Treatment
COVID-19 Therapeutic Options Under Investigation
Galidesivir Triphosphate | Medchemexpress
The Significance of Natural Product Derivatives and Traditional
Medical Product Quality Report – COVID‐19 Issues Issue 1. January to June 2020